Search

everythinglearnresearchcommunity

for

Search:↓

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Targeting and modifying the stem cell niche can improve regenerative therapies.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Early treatment is important for better hair regrowth in elderly women with hair loss.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Targeting colon cancer stem cells might lead to better treatment results.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Male pattern baldness is linked to a higher risk of certain skin cancers, especially on the scalp.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Suppressing certain hormones might help prevent prostate cancer.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.